PB

Pavel Bohdal

Active Director Director DIN 07703201
DIN 07703201 First appointment Jan 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value •••• Premium profile

About Pavel Bohdal

Data last updated:

Pavel Bohdal is a Director at Ingenious Medtech Private Limited (since 2017). The company operates in Healthcare. Ingenious Medtech Private Limited reported revenue of ₹3.58 Cr (FY 2025).

DIN 07703201
Primary Designation Director
Industry Healthcare
First Appointment 27 Jan 2017
Oldest Company Age 9 yrs
Largest company Ingenious Medtech Private Limited · ₹3.58 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ingenious Medtech Private Limited U74999MH2016PTC288080
Director27 Jan 20172016₹3.58 Cr (FY 2025)Active

Board colleagues of Pavel Bohdal

Directorship timeline

Open interactive timeline →
Ingenious Medtech Private Limited
Premium access

Shareholding and investment profile for Pavel Bohdal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavel Bohdal

Pavel Bohdal currently holds 1 directorship: Ingenious Medtech Private Limited (Director, since 27 Jan 2017, revenue ₹3.58 Cr (FY 2025)).

Pavel Bohdal was first appointed on 27 Jan 2017 as Director at Ingenious Medtech Private Limited.

The current boards of Pavel Bohdal's companies include Shantanu Subhash Mayekar (Ingenious Medtech Private Limited), Sneha Shantanu Mayekar (Ingenious Medtech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available